Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Longo

Showing results (101-110 of 484) with videos related to

Pageof 49
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 15, 1992
Human growth hormone promotes engraftment of murine or human T cells in severe combined immunodeficient miceW J Murphy, S K Durum, D L Longo
The Journal of Experimental Medicine|May 1, 1989
Preferential differentiation of T cell receptor specificities based on the MHC glycoproteins encountered during development. Evidence for positive selectionS Marusić-Galesić, D L Longo, A M Kruisbeek
Science (New York, N.Y.)|July 3, 1987
T-cell tumor elimination as a result of T-cell receptor-mediated activationJ D Ashwell, D L Longo, S H Bridges
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1987
Strategies for immunological monitoringW J Urba, A E Maluish, D L Longo
The New England Journal of Medicine|June 27, 1985
Spontaneous alteration of idiotype in a monoclonal B-cell lymphoma. Escape from detection by anti-idiotypeM Raffeld, L Neckers, D L Longo, et al.
Cancer|October 15, 1987
Biologic therapy for the treatment of malignant common epithelial tumors of the ovaryT C Hamilton, R F Ozols, D L Longo
Cancer|February 1, 1987
Current and future uses of recombinant interferon alpha in the treatment of low-grade non-Hodgkin's lymphomaR G Steis, K A Foon, D L Longo
Journal of the National Cancer Institute. Monographs|January 1, 1990
Late complications of Hodgkin's disease managementR C Young, M A Bookman, D L Longo
Biochemical and Biophysical Research Communications|October 4, 1995
Inactivation of NF-kappa B inhibitor I kappa B alpha: ubiquitin-dependent proteolysis and its degradation productC C Li, R M Dai, D L Longo
Seminars in Immunology|August 1, 1996
The huPBL-SCID mouse as a means to examine human immune function in vivoW J Murphy, D D Taub, D L Longo
Pageof 49

Showing results (101-110 of 484) with videos related to

Sort By:
Pageof 49
Proceedings of the National Academy of Sciences of the United States of America|May 15, 1992
Human growth hormone promotes engraftment of murine or human T cells in severe combined immunodeficient miceW J Murphy, S K Durum, D L Longo
The Journal of Experimental Medicine|May 1, 1989
Preferential differentiation of T cell receptor specificities based on the MHC glycoproteins encountered during development. Evidence for positive selectionS Marusić-Galesić, D L Longo, A M Kruisbeek
Science (New York, N.Y.)|July 3, 1987
T-cell tumor elimination as a result of T-cell receptor-mediated activationJ D Ashwell, D L Longo, S H Bridges
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1987
Strategies for immunological monitoringW J Urba, A E Maluish, D L Longo
The New England Journal of Medicine|June 27, 1985
Spontaneous alteration of idiotype in a monoclonal B-cell lymphoma. Escape from detection by anti-idiotypeM Raffeld, L Neckers, D L Longo, et al.
Cancer|October 15, 1987
Biologic therapy for the treatment of malignant common epithelial tumors of the ovaryT C Hamilton, R F Ozols, D L Longo
Cancer|February 1, 1987
Current and future uses of recombinant interferon alpha in the treatment of low-grade non-Hodgkin's lymphomaR G Steis, K A Foon, D L Longo
Journal of the National Cancer Institute. Monographs|January 1, 1990
Late complications of Hodgkin's disease managementR C Young, M A Bookman, D L Longo
Biochemical and Biophysical Research Communications|October 4, 1995
Inactivation of NF-kappa B inhibitor I kappa B alpha: ubiquitin-dependent proteolysis and its degradation productC C Li, R M Dai, D L Longo
Seminars in Immunology|August 1, 1996
The huPBL-SCID mouse as a means to examine human immune function in vivoW J Murphy, D D Taub, D L Longo
Pageof 49